Status:
COMPLETED
e-NOBORI Observational Registry of Nobori DES
Lead Sponsor:
Terumo Europe N.V.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Title Prospective, single-arm, multi-centre, observational registry to further validate safety and efficacy of the Nobori® DES in real-world patients. Objective Primary objective The primary objectiv...
Detailed Description
* Title Prospective, single-arm, multi-centre, observational registry to further validate safety and efficacy of the Nobori® DES in real-world patients. * Primary objective The primary objective of e-...
Eligibility Criteria
Inclusion
- Patient is more or equal 18 years old;
- Patient is, according to hospital routine practice, eligible for percutaneous coronary intervention using DES (and RVD matches available Nobori® DES sizes);
- Patient has been informed of the nature of the study and agrees to its provisions, has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site, wherever such requirement exists.
Exclusion
- None
Key Trial Info
Start Date :
August 25 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 27 2016
Estimated Enrollment :
18000 Patients enrolled
Trial Details
Trial ID
NCT01261273
Start Date
August 25 2010
End Date
May 27 2016
Last Update
October 9 2019
Active Locations (257)
Enter a location and click search to find clinical trials sorted by distance.
1
SMZ-Donauspital Vienna
Vienna, Austria
2
National Heart Foundation Hospital & Research Institute
Dhaka, Bangladesh
3
Republican Clinical Medical Center (Presidential Hospital)
Minsk, Belarus
4
Republican Scientific and Practical Center of Cardiology
Minsk, Belarus